“…These studies include the methods of liquid chromatographic devices combined with ultraviolet (Boulton, Markowitz, & DeVane, 2001;D'Arrigo, Migliardi, Santoro, & Spina, 2006;Olesen, Poulsen, & Linnet, 2001;Sachse, Köller, Härtter, & Hiemke, 2006;Weigmann et al, 2001), diode array (Llorca et al, 2001;Saracino, Koukopoulos, Sani, Amore, & Raggi, 2007;Siva Selva Kumar & Ramanathan, 2016), amperometric (Raggi et al, 2000) and electrochemical detection systems (Aravagiri, Ames, Wirshing, & Marder, 1997;Kobylińska, Buś, & Bukowska-Kiliszek, 2008) and also mass spectrometric systems including MS (Cao, Zhang, Tian, Li, & Rui, 2012;Choong et al, 2009;Zhou et al, 2004) and mainly tandem mass (MS/MS) detectors (Ansermot, Brawand-Amey, Kottelat, & Eap, 2013;Berna, Ackermann, Ruterbories, & Glass, 2002;Cavalcanti Bedor et al, 2015;Kirchherr & Kühn-Velten, 2006;Nirogi et al, 2006;Ravinder, Bapuji, Mukkanti, & Reddy, 2013;Reddy, Reddy, Sreeramulu, & Kanumula, 2007;Uřinovská et al, 2012). Additionally, the use of gas chromatography coupled to nitrogen phosphorus detection (Robertson & McMullin, 2000;Ulrich, 2005), gas chromatography mass spectrometric detection (Da Fonseca et al, 2013;Ikeda et al, 2012) and high-performance thin-layer chromatography (Shah, Shah, Suhagia, & Patel, 2007;Wróblewski, Petruczynik, & Waksmundzka-Hajnos, 2014) have been reported. According to our literature survey, this study is the first study on the determination of olanzapine from schizophrenia patients after intramuscular injection.…”